Rachel Vandenberg
Family Medicine · Manistee, MINPI 1740544873
Payments from drug & device makers
Across 131 payments — averaging $15.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$252
- AbbVie$245
- AstraZeneca$224
- Pfizer$211
- GSK$208
- Takeda Pharmaceuticals U.S.A., Inc.$106
- plus $734 from 21 others
What the payments were for
- Food & beverage$1,980100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $252 |
| AbbVie(2 entities) | 14 | $245 |
| AstraZeneca(2 entities) | 8 | $224 |
| Pfizer | 18 | $211 |
| GSK | 20 | $208 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $106 |
| Lilly USA, LLC | 7 | $97 |
| Alkermes, Inc. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Amgen | 4 | $62 |
| Sunovion Pharmaceuticals Inc. | 8 | $57 |
| Astellas Pharma US Inc | 4 | $52 |
| Myriad Women's Health, Inc. | 1 | $49 |
| Boehringer Ingelheim | 3 | $38 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Bayer | 2 | $29 |
| Lundbeck LLC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $16 |
| Shire North American Group Inc | 1 | $13 |
| Circassia Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
How this compares
$1,980 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 153 | $124,908 |
| TrulicityDulaglutide | 84 | $91,609 |
| PercocetOxycodone Hcl/Acetaminophen | 13 | $82,897 |
| EliquisApixaban | 69 | $78,906 |
| OzempicSemaglutide | 39 | $61,183 |
| MounjaroTirzepatide | 46 | $52,889 |
| JardianceEmpagliflozin | 35 | $40,741 |
| JanuviaSitagliptin Phosphate | 42 | $40,062 |
| FarxigaDapagliflozin Propanediol | 30 | $32,222 |
| XareltoRivaroxaban | 16 | $24,771 |
| RexultiBrexpiprazole | 14 | $16,491 |
| MyrbetriqMirabegron | 20 | $12,638 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $12,320 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $11,551 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $9,822 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $208 | $146,281184 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $97 | $144,498130 claims |
| PfizerEliquis, Premarin | $211 | $81,03982 claims |
| Novo NordiskOzempic | $252 | $61,18339 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $38 | $45,86846 claims |
| AstraZenecaFarxiga | $224 | $32,22230 claims |
| Johnson & JohnsonXarelto | $12 | $24,77116 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $68 | $16,49114 claims |
| Astellas Pharma US IncMyrbetriq | $52 | $12,63820 claims |
| Sanofi-aventis U.S. LLCLantus | $11 | $2,18218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Manistee
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
- Rhonda MejeurGrand Rapids$493K
- Steve LasaterSaint Johns$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.